After the scandal, Murdoch stepped down from a string of company directorships and abandoned a multibillion-dollar bid to acquire satellite broadcaster BSkyB.
Moreover, the company has had a string of regulatory disappointments with medicines like indiplon, a sleeping pill, and more recently an antipsychotic that it was developing with Akzo Nobel.